Pharmacokinetics and Pharmacodynamics of SCT800, a New Recombinant FVIII, in Hemophilia a Mice

Acta Pharmacologica Sinica - United Kingdom
doi 10.1038/aps.2015.121
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Psy112 - Factor Utilization Analysis of Extended Duration and Standard-Acting Recombinant Fviii Treatments for Severe Hemophilia a in Sweden

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pharmacokinetics and Pharmacodynamics of Suxamethonium

Anaesthesia and Intensive Care
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
1997English

Journal of Pharmacokinetics and Pharmacodynamics

Journal of Pharmacokinetics and Pharmacodynamics
Pharmacology
English

Efficacy of Standard Prophylaxis Versus On-Demand Treatment With Bayer's Sucrose-Formulated Recombinant FVIII (rFVIII-FS) in Chinese Children With Severe Hemophilia A

Pediatric Hematology and Oncology
Child HealthOncologyPediatricsPerinatologyHematology
2017English

Developmental Changes in Pharmacokinetics and Pharmacodynamics

Journal of Clinical Pharmacology
Pharmacology
2018English

Ketamine Pharmacokinetics and Pharmacodynamics Are Altered by PGP and BCRP Efflux Transporters in Mice

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2018English

Pharmacokinetics and Pharmacodynamics of a Novel Acetylcholinesterase Inhibitor, DMNG-3

Acta Neurobiologiae Experimentalis
MedicineNeuroscience
2016English

Effect of Route of Administration of Human Recombinant Factor VIII on Its Immunogenicity in Hemophilia a Mice

Journal of Pharmaceutical Sciences
Pharmaceutical Science
2009English

The Pharmacokinetics and the Pharmacodynamics of Cannabinoids

British Journal of Clinical Pharmacology
Pharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy